Erivedge - Drug Details
๐Ÿ“Š Estimates Erivedge Dialyzability By Different_Modalities

Erivedge

Complete Drug Information

Drug Name
Erivedge
Trade Names
Erivedge
Pregnancy Category
AU: X (High risk)
Bioavailability
31.80%
Routes of Administration
Oral
Protein Binding
>99%%
Metabolism
<2% metabolised by CYP2C9, CYP3A4, CYP3A5
Elimination
4 days (continuous use),12 days (single dose)
Excretion
Fecal (82%), Urinary (4.4%)
Formula
C19H14Cl2N2O3S
Molar Mass
421.29
Volume of Distribution
C19H14Cl2N2O3S

๐Ÿคฐ Pregnancy Category Information

Category: AU: X (High risk)

Drugs which have such a high risk of causing permanent damage to the fetus that they should not be used in pregnancy or when there is a possibility of pregnancy.